NASDAQ: CSBRChampions Oncology Inc Stock Ownership - Who owns Champions Oncology?
Insider buying vs selling
Have Champions Oncology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Daniel Newman Mendelson | Director | 2024-01-12 | 1,000 | $6.50 | $6.50kBuy |
| Daniel Newman Mendelson | Director | 2024-01-11 | 2,000 | $6.27 | $12.54kBuy |
| Daniel Newman Mendelson | Director | 2024-01-10 | 2,944 | $6.31 | $18.58kBuy |
| Daniel Newman Mendelson | Director | 2024-01-09 | 3,000 | $6.25 | $18.75kBuy |
| Daniel Newman Mendelson | Director | 2024-01-08 | 1,000 | $6.15 | $6.15kBuy |
| Daniel Newman Mendelson | Director | 2024-01-05 | 2,000 | $6.09 | $12.18kBuy |
| Daniel Newman Mendelson | Director | 2024-01-04 | 3,000 | $6.12 | $18.36kBuy |
| Daniel Newman Mendelson | Director | 2024-01-03 | 500 | $5.83 | $2.92kBuy |
| Daniel Newman Mendelson | Director | 2023-12-21 | 2,500 | $4.92 | $12.30kBuy |
| Daniel Newman Mendelson | Director | 2023-12-20 | 2,100 | $4.82 | $10.12kBuy |
CSBR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CSBR insiders and whales buy or sell their stock.
CSBR Shareholders
What type of owners hold Champions Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Michael Maurice Brown | 172.45% | 23,442,589 | $117.92M | Insider |
| M. James Barrett | 137.93% | 18,750,000 | $94.31M | Insider |
| David M. Mott | 137.93% | 18,750,000 | $94.31M | Insider |
| Peter J. Barris | 137.93% | 18,750,000 | $94.31M | Insider |
| Krishna Kittu Kolluri | 137.93% | 18,750,000 | $94.31M | Insider |
| Patrick J. Kerins | 137.93% | 18,750,000 | $94.31M | Insider |
| Peter W. Sonsini | 137.93% | 18,750,000 | $94.31M | Insider |
| Forest Baskett | 137.93% | 18,750,000 | $94.31M | Insider |
| Scott D. Sandell | 137.93% | 18,750,000 | $94.31M | Insider |
| Ryan D. Drant | 137.93% | 18,750,000 | $94.31M | Insider |
CSBR vs Biotech Stocks
Champions Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.